Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with Enterobacter bacteremia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 21, Issue 8, 2002, Pages 577-581

  Lee, S O ^a   Kim, Y S ^a   Kim, B N ^a   Kim, M N ^a   Woo, J H ^a,b   Ryu, J ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b NONE   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZATHIOPRINE; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN; TACROLIMUS;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CANCER; CANCER CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG SENSITIVITY; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BACTEREMIA; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036039370     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-002-0772-7     Document Type: Article

References (22)

1. Major trends in the microbial etiology of nosocomial infection
2. Septicemia in 980 patients at a university hospital in Berlin: Prospective studies during 4 selected years between 1979 and 1989
3. Characterization of beta-lactamases
4. β-lactamases of gram-negative bacteria: New challenges for new drugs
5. Enterobacter spp.: Pathogens poised to flourish at the turn of the century
6. Endemic emergence of cephalosporin-resistant Enterobacter: Relation to prior therapy
7. Prior antimicrobial therapy and resistance of Enterobacter, Citrobacter and Serratia to third-generation cephalosporins
8. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
9. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamase-producing organisms
10. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
11. CDC definitions for nosocomial infections
12. Enterobacter cloacae: Bacteremia, epidemiology, and antibiotic resistance
13. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery
14. The use of colonization rate and epidemic index as tools to illustrate the epidemiology of faecal Enterobacteriaceae strains in Swedish neonatal wards
15. Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit
16. Incidence of pneumonia in mechanically ventilated patients with sucralfate or cimetidine as prophylaxis for stress bleeding: Bacterial colonization of the stomach
17. Comparative in vitro susceptibilities of eight Enterobacter species, with special reference to Enterobacter sakazakii
18. Role of a cefoxitin-inducible β-lactamase in a case of breakthrough bacteremia
19. In vivo selection of resistance to multiple cephalosporins by Enterobacter cloacae
20. Broad-spectrum β-lactam resistance in Enterobacter: Emergence during treatment and mechanisms of resistance
21. Clinical consequences of development of resistance to third-generation cephalosporins